![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/496 | (2006.01) |
A61K 31/496 | (2013.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/519 | (2013.01) | ||
A61K 31/519 | (2006.01) | ||
A61K 31/5375 | (2013.01) | ||
A61K 31/506 | (2013.01) | ||
A61K 31/5375 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61K 31/337 | (2013.01) | ||
A61K 31/4184 | (2013.01) | ||
A61K 31/4412 | (2013.01) | ||
A61K 31/4439 | (2013.01) | ||
A61K 31/517 | (2013.01) | ||
A61K 31/5377 | (2013.01) | ||
A61K 31/635 | (2013.01) |
(11) | Patento numeris | 3340989 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16760803.3 |
Europos patento paraiškos padavimo data | 2016-08-24 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-07-04 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-16 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2016/055050 |
Data | 2016-08-24 |
(87) | Numeris | WO 2017/037579 |
Data | 2017-03-09 |
(30) | Numeris | Data | Šalis |
201562211080 P | 2015-08-28 | US | |
201562243337 P | 2015-10-19 | US | |
201562250574 P | 2015-11-04 | US |
(72) |
HALILOVIC, Ensar , US
CAPONIGRO, Giordano , US
HORN-SPIROHN, Thomas , US
LEHAR, Joseph , US
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | MDM2 INHIBITORS AND COMBINATIONS THEREOF |
MDM2 INHIBITORS AND COMBINATIONS THEREOF |